Results 251 to 260 of about 143,509 (313)

Glucotypes in patients with type 2 diabetes and either diabetic kidney disease or end stage kidney disease under different anti-diabetic treatments. [PDF]

BMC Endocr Disord
Chou YY, Liu FH, Lin CH.
europepmc   +1 more source

Impact of Sleep-disordered Breathing Management in Primary Care on Systemic Hypertension Control: Protocol for the METASLEEP Implementation Trial. [PDF]

Open Respir Arch
Pinilla L, Benítez ID, Moncusí-Moix A, Torres G, Casanovas-Salvatella O, Juez-Garcia I, Gracia-Lavedan E, Alonso-Fernández A, Caballero-Eraso C, Cano-Pumarega I, Boira I, Egea C, González M, Mediano O, Roncero A, Roche-Campo F, Sánchez-Quiroga MÁ, Chai-Coetzer CL, Sánchez-de-la-Torre M, Barbé F, de Batlle J, Spanish Sleep Network.   +21 more
europepmc   +1 more source

Economic evaluation of insulin glargine compared with human insulin for youth with type 1 diabetes in Tanzania and Bangladesh. [PDF]

PLoS One
Prust ML, Lalama CM, Kehlenbrink S, Akinola OA, Nyarubamba R, Flabe AH, Foulds A, Ogle GD, Majaliwa E, Zabeen B, Ramaiya K, Garvin A, Luo J.   +12 more
europepmc   +1 more source

Nocturnal voiding dysfunctions :

, 2009
Vande Walle, Johan, Tekgul, Serdar
openalex   +1 more source

Luseogliflozin Suppresses Late-Night Basal Glycemic Variability in Type 2 Diabetes: A Retrospective Observational Study. [PDF]

Cureus
Yamauchi K.
europepmc   +1 more source

Abnormalities of the nocturnal blood pressure profile: significance, diagnostic possibilities, and therapeutic approaches

Zhanna Kobalava, E. A. Troitskaya
openalex   +2 more sources